Literature DB >> 16567403

Characterization and application of a novel RNA aptamer against the mouse prion protein.

Satoru Sekiya1, Ken Noda, Fumiko Nishikawa, Takashi Yokoyama, Penmetcha K R Kumar, Satoshi Nishikawa.   

Abstract

In order to isolate RNA aptamers against the mouse prion protein (mPrP), we carried out in vitro selection from RNA pools containing a 30-nucleotide randomized region. Aptamer 60-3 was found to have a high affinity for mPrP (K(d) = 5.6 +/- 1.5 nM), and 2'-fluoro-pyrimidine modifications for RNase resistance did not abolish its binding activity (K(d) = 22 +/- 4 nM). Following 5' biotinylation, aptamer 60-3 specifically detected PrP in mouse brain homogenate in a Northwestern blotting assay. To determine the mPrP-aptamer binding region, we performed protein-deletion-mutant analysis and competition-binding analysis using heparin. The results showed that aptamer 60-3 appears to have binding sites located between amino acids 23-108.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16567403     DOI: 10.1093/jb/mvj046

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  14 in total

1.  Anti-bovine prion protein RNA aptamer containing tandem GGA repeat interacts both with recombinant bovine prion protein and its beta isoform with high affinity.

Authors:  Kazuyoshi Murakami; Fumiko Nishikawa; Ken Noda; Takashi Yokoyama; Satoshi Nishikawa
Journal:  Prion       Date:  2008-04-17       Impact factor: 3.931

2.  Melanin or a Melanin-Like Substance Interacts with the N-Terminal Portion of Prion Protein and Inhibits Abnormal Prion Protein Formation in Prion-Infected Cells.

Authors:  Taichi Hamanaka; Keiko Nishizawa; Yuji Sakasegawa; Ayumi Oguma; Kenta Teruya; Hiroshi Kurahashi; Hideyuki Hara; Suehiro Sakaguchi; Katsumi Doh-Ura
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 3.  Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy.

Authors:  Karen Vana; Chantal Zuber; Daphne Nikles; Stefan Weiss
Journal:  Cell Mol Neurobiol       Date:  2006-12-07       Impact factor: 5.046

Review 4.  Aptamer and its applications in neurodegenerative diseases.

Authors:  Jing Qu; Shuqing Yu; Yuan Zheng; Yan Zheng; Hui Yang; Jianliang Zhang
Journal:  Cell Mol Life Sci       Date:  2016-08-25       Impact factor: 9.261

Review 5.  Aptamers against prion proteins and prions.

Authors:  Sabine Gilch; Hermann M Schätzl
Journal:  Cell Mol Life Sci       Date:  2009-04-25       Impact factor: 9.261

6.  Generation of highly specific aptamers via micromagnetic selection.

Authors:  Seung Soo Oh; Jiangrong Qian; Xinhui Lou; Yanting Zhang; Yi Xiao; H Tom Soh
Journal:  Anal Chem       Date:  2009-07-01       Impact factor: 6.986

7.  Screening of DNA aptamer against mouse prion protein by competitive selection.

Authors:  Daisuke Ogasawara; Hijiri Hasegawa; Kiyotoshi Kaneko; Koji Sode; Kazunori Ikebukuro
Journal:  Prion       Date:  2007-10-25       Impact factor: 3.931

Review 8.  Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders.

Authors:  Islauddin Khan; Kumari Preeti; Valencia Fernandes; Dharmendra Kumar Khatri; Shashi Bala Singh
Journal:  Cell Mol Neurobiol       Date:  2021-05-01       Impact factor: 4.231

9.  Cross-talk between prion protein and quadruplex-forming nucleic acids: a dynamic complex formation.

Authors:  Paola Cavaliere; Bruno Pagano; Vincenzo Granata; Stephanie Prigent; Human Rezaei; Concetta Giancola; Adriana Zagari
Journal:  Nucleic Acids Res       Date:  2012-10-27       Impact factor: 16.971

Review 10.  Characterization of aptamer-protein complexes by X-ray crystallography and alternative approaches.

Authors:  Vincent J B Ruigrok; Mark Levisson; Johan Hekelaar; Hauke Smidt; Bauke W Dijkstra; John Van der Oost
Journal:  Int J Mol Sci       Date:  2012-08-22       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.